Role of American Society of Clinical Oncology in low- and middle-income countries

Jyoti D. Patel, Matthew D. Galsky, Anees B. Chagpar, Doug Pyle, Patrick J. Loehrer

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

The American Society of Clinical Oncology (ASCO) is a global community of health care professionals whose stated purpose is to "make a world of difference" by improving cancer care around the world. Unfortunately, cancer survival rates vary significantly among countries with differing financial and infrastructural resources. Because ASCO is a professional oncology society committed to conquering cancer through research, education, prevention, and delivery of high-quality patient care, it is ideally suited to address this issue. ASCO could bring together oncology professionals and other necessary stakeholders from around the world to improve cancer care and lessen suffering for patients worldwide. As part of the ongoing commitment of ASCO to the future of cancer care, the Leadership Development Program was created to foster the leadership skills of early and midcareer oncologists and provide these participants with a working knowledge of the depth and breadth of the organization. As participants in the inaugural class of the ASCO Leadership Development Program, we were charged with investigating how ASCO might favorably affect cancer prevention and treatment in resource-poor countries in a cost-effective, scalable, and sustainable fashion. ASCO can significantly influence cancer care in low- and middle-income countries through a comprehensive approach that promotes cancer awareness and education, improves clinical practice by identifying and removing barriers to delivery of quality cancer care, and fosters innovation to initiate novel solutions to complex problems.

Original languageEnglish (US)
Pages (from-to)3097-3102
Number of pages6
JournalJournal of Clinical Oncology
Volume29
Issue number22
DOIs
StatePublished - Aug 1 2011

Fingerprint

Medical Oncology
Neoplasms
Quality of Health Care
Education
Community Health Services
Patient Care
Survival Rate
Organizations
Costs and Cost Analysis
Research

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Role of American Society of Clinical Oncology in low- and middle-income countries. / Patel, Jyoti D.; Galsky, Matthew D.; Chagpar, Anees B.; Pyle, Doug; Loehrer, Patrick J.

In: Journal of Clinical Oncology, Vol. 29, No. 22, 01.08.2011, p. 3097-3102.

Research output: Contribution to journalReview article

Patel, Jyoti D. ; Galsky, Matthew D. ; Chagpar, Anees B. ; Pyle, Doug ; Loehrer, Patrick J. / Role of American Society of Clinical Oncology in low- and middle-income countries. In: Journal of Clinical Oncology. 2011 ; Vol. 29, No. 22. pp. 3097-3102.
@article{b5914f5688da4e749bc69da8f3a154ec,
title = "Role of American Society of Clinical Oncology in low- and middle-income countries",
abstract = "The American Society of Clinical Oncology (ASCO) is a global community of health care professionals whose stated purpose is to {"}make a world of difference{"} by improving cancer care around the world. Unfortunately, cancer survival rates vary significantly among countries with differing financial and infrastructural resources. Because ASCO is a professional oncology society committed to conquering cancer through research, education, prevention, and delivery of high-quality patient care, it is ideally suited to address this issue. ASCO could bring together oncology professionals and other necessary stakeholders from around the world to improve cancer care and lessen suffering for patients worldwide. As part of the ongoing commitment of ASCO to the future of cancer care, the Leadership Development Program was created to foster the leadership skills of early and midcareer oncologists and provide these participants with a working knowledge of the depth and breadth of the organization. As participants in the inaugural class of the ASCO Leadership Development Program, we were charged with investigating how ASCO might favorably affect cancer prevention and treatment in resource-poor countries in a cost-effective, scalable, and sustainable fashion. ASCO can significantly influence cancer care in low- and middle-income countries through a comprehensive approach that promotes cancer awareness and education, improves clinical practice by identifying and removing barriers to delivery of quality cancer care, and fosters innovation to initiate novel solutions to complex problems.",
author = "Patel, {Jyoti D.} and Galsky, {Matthew D.} and Chagpar, {Anees B.} and Doug Pyle and Loehrer, {Patrick J.}",
year = "2011",
month = "8",
day = "1",
doi = "10.1200/JCO.2011.35.6378",
language = "English (US)",
volume = "29",
pages = "3097--3102",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "22",

}

TY - JOUR

T1 - Role of American Society of Clinical Oncology in low- and middle-income countries

AU - Patel, Jyoti D.

AU - Galsky, Matthew D.

AU - Chagpar, Anees B.

AU - Pyle, Doug

AU - Loehrer, Patrick J.

PY - 2011/8/1

Y1 - 2011/8/1

N2 - The American Society of Clinical Oncology (ASCO) is a global community of health care professionals whose stated purpose is to "make a world of difference" by improving cancer care around the world. Unfortunately, cancer survival rates vary significantly among countries with differing financial and infrastructural resources. Because ASCO is a professional oncology society committed to conquering cancer through research, education, prevention, and delivery of high-quality patient care, it is ideally suited to address this issue. ASCO could bring together oncology professionals and other necessary stakeholders from around the world to improve cancer care and lessen suffering for patients worldwide. As part of the ongoing commitment of ASCO to the future of cancer care, the Leadership Development Program was created to foster the leadership skills of early and midcareer oncologists and provide these participants with a working knowledge of the depth and breadth of the organization. As participants in the inaugural class of the ASCO Leadership Development Program, we were charged with investigating how ASCO might favorably affect cancer prevention and treatment in resource-poor countries in a cost-effective, scalable, and sustainable fashion. ASCO can significantly influence cancer care in low- and middle-income countries through a comprehensive approach that promotes cancer awareness and education, improves clinical practice by identifying and removing barriers to delivery of quality cancer care, and fosters innovation to initiate novel solutions to complex problems.

AB - The American Society of Clinical Oncology (ASCO) is a global community of health care professionals whose stated purpose is to "make a world of difference" by improving cancer care around the world. Unfortunately, cancer survival rates vary significantly among countries with differing financial and infrastructural resources. Because ASCO is a professional oncology society committed to conquering cancer through research, education, prevention, and delivery of high-quality patient care, it is ideally suited to address this issue. ASCO could bring together oncology professionals and other necessary stakeholders from around the world to improve cancer care and lessen suffering for patients worldwide. As part of the ongoing commitment of ASCO to the future of cancer care, the Leadership Development Program was created to foster the leadership skills of early and midcareer oncologists and provide these participants with a working knowledge of the depth and breadth of the organization. As participants in the inaugural class of the ASCO Leadership Development Program, we were charged with investigating how ASCO might favorably affect cancer prevention and treatment in resource-poor countries in a cost-effective, scalable, and sustainable fashion. ASCO can significantly influence cancer care in low- and middle-income countries through a comprehensive approach that promotes cancer awareness and education, improves clinical practice by identifying and removing barriers to delivery of quality cancer care, and fosters innovation to initiate novel solutions to complex problems.

UR - http://www.scopus.com/inward/record.url?scp=80051649556&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051649556&partnerID=8YFLogxK

U2 - 10.1200/JCO.2011.35.6378

DO - 10.1200/JCO.2011.35.6378

M3 - Review article

C2 - 21709190

AN - SCOPUS:80051649556

VL - 29

SP - 3097

EP - 3102

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 22

ER -